Report ID: SQMIG35A2872
Report ID:
SQMIG35A2872 |
Region:
Global |
Published Date: October, 2024
Pages:
190
|
Tables:
86 |
Figures:
74
As per the ophthalmology devices market analysis, North America held the largest share in 2023. A high population of older adults and rising prevalence of chronic eye conditions resulting from factors, such as high stress and unhealthy lifestyles; ultimately leading to diabetic retinopathy, are considered high impact rendering drivers for the market. In addition, the incorporation of new reimbursement models for ophthalmologic treatment and a stringent regulatory framework aimed at patients’ safety, is expected to fuel product demand in this region. The U.S. possesses a well-developed healthcare system with leading academic institutions and research facilities. This encourages innovations in ophthalmic devices in terms of minimally invasive surgical techniques, advanced diagnostic instruments, and personalized medicine approaches, thereby propelling growth for the market. The U.S. spends significantly on healthcare compared to other developed countries, with total healthcare spending projected to reach $4.8 trillion by 2030. This translates into increased funding for specialized therapies and devices, including eye care.
As per the ophthalmology devices market outlook, Asia Pacific is anticipated to grow at the fastest CAGR from 2024 to 2031. Rising prevalence of eye disorders, such as glaucoma, and increasing awareness about these disorders due to the rapidly improving healthcare infrastructure. The growth can be attributed to the increasing outsourcing activities for ophthalmology devices by key industry players, such as Alcon, Inc. Moreover, the increasing awareness about advanced corrective vision treatments is a key growth-driving factor for emerging economies, such as China and India. The establishment of more ophthalmic centers, the availability of skilled professionals, and advancements in technologies like telemedicine across India create lucrative growth for several market players within India. The Indian government’s National Programme for Prevention and Control of Blindness (NPCB) and other initiatives raise awareness about eye health and prioritize access to essential eye care services. These programs drive demand for affordable and effective ophthalmic diagnostic devices.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2872